Watson, JA;
Bryan, K;
Williams, R;
Popov, S;
Vujanic, G;
Coulomb, A;
Boccon-Gibod, L;
... O'Sullivan, M; + view all
(2013)
miRNA profiles as a predictor of chemoresponsiveness in Wilms' tumor blastema.
PLoS One
, 8
(1)
, Article e53417. 10.1371/journal.pone.0053417.
Preview |
PDF
1383814.pdf Download (407kB) |
Abstract
The current SIOP treatment protocol for Wilms' tumor involves pre-operative chemotherapy followed by nephrectomy. Not all patients benefit equally from such chemotherapy. The aim of this study was to generate a miRNA profile of chemo resistant blastemal cells in high risk Wilms' tumors which might serve as predictive markers of therapeutic response at the pre-treatment biopsy stage. We have shown here that unsupervised hierarchical clustering of genome-wide miRNA expression profiles can clearly separate intermediate risk tumors from high risk tumors. A total of 29 miRNAs were significantly differentially expressed between post-treatment intermediate risk and high risk groups, including miRNAs that have been previously linked to chemo resistance in other cancer types. Furthermore, 7 of these 29 miRNAs were already at the pre-treatment biopsy stage differentially expressed between cases ultimately deemed intermediate risk compared to high risk. These miRNA alterations include down-regulation in high risk cases of miR-193a.5p, miR-27a and the up-regulation of miR-483.5p, miR-628.5p, miR-590.5p, miR-302a and miR-367. The demonstration of such miRNA markers at the pre-treatment biopsy stage could permit stratification of patients to more tailored treatment regimens.
Type: | Article |
---|---|
Title: | miRNA profiles as a predictor of chemoresponsiveness in Wilms' tumor blastema. |
Location: | United States |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1371/journal.pone.0053417 |
Publisher version: | http://dx.doi.org/10.1371/journal.pone.0053417 |
Language: | English |
Additional information: | © 2013 Watson et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This project was funded by the Health Research Board (HRB) of Ireland, grant number: HRB MRCG 2008/1; website: http://www.hrb.ie/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Biology and Cancer Dept |
URI: | https://discovery.ucl.ac.uk/id/eprint/1383814 |
Archive Staff Only
View Item |